Inventor · disambiguated record
Takenao Odagami
Also filed as: ODAGAMI TAKENAO
10 granted patents·16 pending applications·14 citations·filing 2009–2023
81Inventor score
Files withPRISM PHARMA CO LTD11PRISM BIOLAB CO LTD6KOUJI HIROYUKI4ODAGAMI TAKENAO2PRISM BIOLAB CORP2
Top patents by PatentIndex Score
26 records- 0185US8455488B2Alpha helix mimetics and methods relating theretoODAGAMI TAKENAO·Filed 2009·Granted Jun 4, 2013·12 cites·5 claims
- 0270US8691819B2Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditionsKOUJI HIROYUKI·Filed 2009·Granted Apr 8, 2014·2 cites·26 claims
- 0354US2025250282A1Novel seven-membered ring-fused compoundsPRISM BIOLAB CO LTD·Filed 2023·Application pending·0 cites
- 0453US9700569B2Prevention or treatment agent for hepatic fibrosisPRISM PHARMA CO LTD·Filed 2013·Granted Jul 11, 2017·0 cites·4 claims
- 0551US9126981B2Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditionsPRISM BIOLAB CORP·Filed 2014·Granted Sep 8, 2015·0 cites·1 claims
- 0651US2024309006A1Novel bicyclic compoundsPRISM BIOLAB CO LTD·Filed 2022·Application pending·0 cites
- 0749US10265331B2Prevention or treatment agent for hepatic fibrosisPRISM PHARMA CO LTD·Filed 2017·Granted Apr 23, 2019·0 cites·2 claims
- 0849US2018305373A1Alpha helix mimetics and methods relating theretoPRISM BIOLAB CO LTD·Filed 2018·Application pending·0 cites
- 0948US2016166578A1Method for treating type i and type ii diabetesPRISM PHAMA LTD·Filed 2013·Application pending·0 cites
- 1045US9193734B2Alpha helix mimetics and methods relating theretoPRISM BIOLAB CORP·Filed 2013·Granted Nov 24, 2015·0 cites·15 claims
- 1145US9040531B2Alpha helix mimetics and methods relating theretoODAGAMI TAKENAO·Filed 2010·Granted May 26, 2015·0 cites·7 claims
- 1245US2023374034A1Novel bicyclic compoundsPRISM BIOLAB CO LTD·Filed 2021·Application pending·0 cites
- 1343US11369623B2Anticancer combination of a CBP/catenin inhibitor and an immune checkpoint inhibitorPRISM PHARMA CO LTD·Filed 2016·Granted Jun 28, 2022·0 cites·1 claims
- 1443US9682996B2Alpha helix mimetic compositions for treating cancer and other CBP/catenin-mediated diseases and conditionsPRISM BIOLAB CO LTD·Filed 2015·Granted Jun 20, 2017·0 cites·27 claims
- 1542US10017522B2Alpha helix mimetics and methods relating theretoPRISM BIOLAB CO LTD·Filed 2015·Granted Jul 10, 2018·0 cites·17 claims
- 1642US2016318938A1CRYSTALS (2) OF PYRAZINO[2,1-c][1,2,4]TRIAZINE COMPOUNDPRISM PHARMA CO LTD·Filed 2014·Application pending·0 cites
- 1742US2016318957A1CRYSTAL (1) OF PYRAZINO[2,1-c][1,2,4]TRIAZINE COMPOUNDPRISM PHARMA CO LTD·Filed 2014·Application pending·0 cites
- 1841US2016215007A1Method of producing pyrazino[2,1-c][1,2,4]triazine compoundPRISM PHARMA CO LTD·Filed 2014·Application pending·0 cites
- 1941US2014275295A1Method for treating type i and type ii diabetesKOUJI HIROYUKI·Filed 2012·Application pending·0 cites
- 2038US2016166577A1Treatment of pulmonary fibrosis using an inhibitor of cbp/cateninPRISM PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 2138US2015283145A1Treatment of hyperproliferative and pre-cancerous skin diseases using an inhibitor of cbp/cateninPRISM PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 2238US2015274751A1Treatment of scleroderma using an inhibitor of cbp/cateninPRISM PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 2338US2016263131A1Treatment of hepatic fibrosis using an inhibitor of cbp/cateninKOUJI HIROYUKI·Filed 2014·Application pending·0 cites
- 2438US2015284393A1Methods for treating eye disordersPRISM PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 2537US2016244453A1Treatment of viral and infectious diseases using an inhibitor of cbp/cateninPRISM PHARMA CO LTD·Filed 2013·Application pending·0 cites
- 2632US2014051706A1Alpha helix mimetics and methods relating theretoKOUJI HIROYUKI·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →